| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000028962 |
| Receipt No. | R000033145 |
| Official scientific title of the study | Comparative study of symptom improvement effect of vonoprazan and esomeprazole in patients with reflux esophagitis. |
| Date of disclosure of the study information | 2017/09/01 |
| Last modified on | 2017/09/01 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Comparative study of symptom improvement effect of vonoprazan and esomeprazole in patients with reflux esophagitis. | |
| Title of the study (Brief title) | Study of symptom improvement effect of gastric secretion inhibitors in patients with reflux esophagitis. | |
| Region |
|
|
| Condition | ||
| Condition | Reflex esophagitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the clinical symptom improvement effect of Vonoprazan compared with esomeprazole |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The change of total score evaluated using FSSG |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Vonoprazan 20mg oral once a day, 4weeks | |
| Interventions/Control_2 | Esomeprazole 20mg oral once a day, 4weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.The patients aged 20 years or older.
2.The patients who are diagnosed as having reflux esophagitis by physician. 3.The patients who have GERD symptom (heartburn or acid regurgitation) at least once a week. |
|||
| Key exclusion criteria | 1.The patients with warning signs such as vomiting, gastrointestinal bleeding and sudden weight loss.
2.The patients with confirmed or suspected malignant diseases. 3.The patients with a history of gastrointestinal resection of vagotomy. 4.The patients with a history of irritable bowel syndrome. 5.The patients whose participation in this study would be contraindicated due to complications such as serious heaptic, renal or heart disease. 6.The Pregnant patients or possibly pregnant patients. 7.The patients prohibited the participant of this study by their attending physicians. 8.The patients who took esomeprazole or vonoprazan within 4 weeks. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Tsutomu Masuda |
| Organization | Ikoma Gastorenteroproctorogy Clinic |
| Division name | Gastroenterology |
| Address | 7-10 Honmachi, Ikoma-shi, Nara |
| TEL | 0743-71-8050 |
| t-masuda@gaia.eonet.ne.jp | |
| Public contact | |
| Name of contact person | Tsutomu Masuda |
| Organization | Ikoma Gastorenteroproctorogy Clinic |
| Division name | Gastroenterology |
| Address | 7-10 Honmachi, Ikoma-shi, Nara |
| TEL | 0743-71-8050 |
| Homepage URL | |
| t-masuda@gaia.eonet.ne.jp | |
| Sponsor | |
| Institute | Ikoma Gastorenteroproctorogy Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ikoma Gastorenteroproctorogy Clinic |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033145 |